Ancillary Studies to Ongoing Clinical Projects (RP1 Clinical Trial Not Allowed)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
This contract seeks applications for conducting time-sensitive ancillary studies linked to active, ongoing clinical projects, which may be interventional clinical trials, observational studies, or disease-specific repositories. These parent projects should have ongoing collection of patient samples or clinical data and provide a well-characterized patient cohort along with the necessary infrastructure, data, and biological specimens for the ancillary studies. The goal is to leverage existing funded resources to maximize the value and impact of ongoing clinical research, thereby enhancing the scientific knowledge of diseases or organ systems. The initiative encourages proposals that build on current investments to improve understanding and potentially identify new diagnostic, treatment, or prevention targets. The funding opportunity is issued by the National Institutes of Health under the Department of Health and Human Services, with specific coordination by the National Institute of Arthritis and Musculoskeletal and Skin Diseases. This notice explicitly excludes RP1 clinical trials, focusing instead on ancillary studies that complement and amplify the scientific outcomes of the parent projects. Applicants can direct inquiries to the provided NIH contact email.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
This Notice of Funding Opportunity (NOFO) solicits applications that propose to conduct time-sensitive ancillary studies in conjunction with privately or publicly funded, active, ongoing clinical projects (parent projects). The parent project can be an interventional clinical trial, or a clinical study such as an observational study, or a disease-specific repository that will be actively collecting patient samples or clinical data. The parent project(s) should provide a cohort of well-characterized patients, infrastructure, data, and biological samples for the ancillary study. The objective of this NOFO is to provide a flexible mechanism to leverage currently funded resources and maximize the return on existing investments in parent projects. Successful ancillary studies will enhance the scientific content and value of the parent projects, improve the research community’s understanding of a disease or organ system and thus may identify novel targets for diagnosis, treatment, and prevention of disease.
